Christopher Bowden

Track

Insider profile

Currently holds positions in Agios Pharmaceuticals Inc, Viridian Therapeutics Inc and Alaunos Therapeutics Inc

Positions

Position Company Period
Chief Medical Officer Agios Pharmaceuticals Inc May 14, 2014 -
Independent Director Viridian Therapeutics Inc Aug. 10, 2017 -
Independent Director Alaunos Therapeutics Inc Oct. 8, 2019 -
Christopher Bowden's trades of Agios Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-22 2021-06-18
PlS Planned sale
10,427 -35.2%
175.11
US$2,932,103 		10,427 -35.2% 175.11 US$2,932,103
2021-06-11 2021-06-10
PlS Planned sale
61,370 +34.3%
304.46
US$3,734,397 		61,370 +34.3% 304.46 US$3,734,397
2021-06-11 2021-06-09
PlS Planned sale
47,975 +37.9%
279.77
US$3,992,442 		47,975 +37.9% 279.77 US$3,992,442
2021-06-09 2021-06-08
PlS Planned sale
6,675 -30.1%
60.07
US$400,939 		6,675 -30.1% 60.07 US$400,939
2021-06-09 2021-06-07
PlS Planned sale
4,268 -21.6%
60.04
US$256,232 		4,268 -21.6% 60.04 US$256,232
2020-05-21 2020-05-20
PlS Planned sale
3,583 -30.1%
50.01
US$179,200 		3,583 -30.1% 50.01 US$179,200
2020-02-18 2020-02-13
PlS Planned sale
7,100 -81.1%
50.16
US$356,112 		7,100 -81.1% 50.16 US$356,112
2020-02-13 2020-02-11
PlS Planned sale
621 -27.3%
50.02
US$31,063 		621 -27.3% 50.02 US$31,063
2020-02-06 2020-02-04
PlS Planned sale
35,447 -95.6%
50.10
US$1,776,026 		35,447 -95.6% 50.10 US$1,776,026
2020-02-06 2020-02-04
PlS Planned sale
14,191 -89.6%
50.03
US$709,963 		14,191 -89.6% 50.03 US$709,963
2019-04-03 2019-04-01
PlS Planned sale
100 -1.4%
68.72
US$6,872 		100 -1.4% 68.72 US$6,872
2019-04-03 2019-04-01
PlS Planned sale
1,500 -17.0%
68.09
US$102,135 		1,500 -17.0% 68.09 US$102,135
2019-04-03 2019-04-01
PlS Planned sale
2,546 -22.4%
66.85
US$170,200 		2,546 -22.4% 66.85 US$170,200
2019-04-03 2019-04-01
PlS Planned sale
5,854 -34.0%
66.03
US$386,540 		5,854 -34.0% 66.03 US$386,540
2019-03-19 2019-03-15
PlS Planned sale
1,300 -15.2%
64.64
US$84,032 		1,300 -15.2% 64.64 US$84,032
2019-03-19 2019-03-15
PlS Planned sale
8,700 -50.5%
64.09
US$557,583 		8,700 -50.5% 64.09 US$557,583
2018-07-12 2018-07-10
PlS Planned sale
1,200 -41.0%
86.42
US$103,704 		1,200 -41.0% 86.42 US$103,704
2018-06-14 2018-06-12
PlS Planned sale
200 -18.5%
93.37
US$18,674 		200 -18.5% 93.37 US$18,674
2018-05-15 2018-05-11
PlS Planned sale
1,160 -56.8%
85.14
US$98,762 		1,160 -56.8% 85.14 US$98,762
2018-05-15 2018-05-11
PlS Planned sale
840 -29.2%
84.81
US$71,240 		840 -29.2% 84.81 US$71,240
2018-04-16 2018-04-12
PlS Planned sale
700 -44.3%
85.68
US$59,976 		700 -44.3% 85.68 US$59,976
2018-04-16 2018-04-12
PlS Planned sale
1,300 -45.1%
84.78
US$110,214 		1,300 -45.1% 84.78 US$110,214
2018-03-16 2018-03-14
PlS Planned sale
300 -25.4%
82.90
US$24,870 		300 -25.4% 82.90 US$24,870
2018-03-16 2018-03-14
PlS Planned sale
1,700 -59.0%
82.23
US$139,791 		1,700 -59.0% 82.23 US$139,791
2018-02-20 2018-02-16
PlS Planned sale
500 -36.2%
78.08
US$39,040 		500 -36.2% 78.08 US$39,040
2018-02-20 2018-02-16
PlS Planned sale
1,500 -52.1%
77.51
US$116,265 		1,500 -52.1% 77.51 US$116,265
2018-02-05 2018-02-01
PlS Planned sale
685 -43.7%
79.23
US$54,273 		685 -43.7% 79.23 US$54,273
2017-09-13 2017-09-11
PlS Planned sale
6,000 -87.2%
65.00
US$390,000 		6,000 -87.2% 65.00 US$390,000
2015-06-02 2015-06-01
PlS Planned sale
5,000 -100.0%
120.67
US$603,350 		5,000 -100.0% 120.67 US$603,350